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Adenovirus ElA-dependent trans activation of the adenovirus E2 gene involves the activation of the cellular
transcription factor E2F. E2F binding sites have also been identified in the 5'-flanking region of a number of
cellular genes, raising the possibility that such genes are targets for ElA trans activation. We now demonstrate
that two genes that possess E2F recognition sites, N-myc and DHFR, are stimulated by ElA, dependent on the
E2F sites. We also find that although there are multiple E2F sites in these promoters, a single intact E2F
binding site is sufficient for ElA-mediated induction, although not to the full wild-type level. These results thus
demonstrate that a variety of cellular genes that possess E2F binding sites are subject to ElA trans activation.
Moreover, since the products of most of these genes are likely critical for cellular proliferation, there are
obvious consequences of this trans activation for cellular phenotype.
Viral systems have proved to be invaluable tools in the
study of complex cellular events. The DNA viruses that
infect the nuclei of eukaryotic cells make use of the host cell
transcriptional machinery, and thus the lessons learned from
the study of these viruses have been informative for general
considerations of eukaryotic transcription control mecha-
nisms (10, 18). For instance, it is clear that most of the viral
transcription units employ promoters and enhancers that
utilize cellular transcription factors in a manner similar to
that of their cellular counterparts. An added advantage of the
viral systems is the fact that many viruses encode regulatory
proteins that control the activity of some of these cellular
transcription factors. These so-called trans-activating genes
are responsible for the efficient stimulation of viral transcrip-
tion during the lytic replication cycle. Perhaps the best
studied of these viral regulatory genes is the ElA gene of
adenovirus. The ElA gene products are not DNA binding
proteins (5), and thus it is presumed that the action of ElA to
stimulate transcription must be indirect. Indeed, several
reports have shown that this ElA-dependent activation
process involves the targeting of cellular transcription fac-
tors that bind to the promoter regions of the early viral genes
(reviewed in reference 17). In some cases, the DNA binding
activity of the factor is stimulated, whereas in other cases,
no change in binding is seen, suggesting a change in function.
DNA binding assays identified a factor termed E2F that
bound to functionally important sequences of the viral E2
promoter and which was increased in abundance upon viral
infection (12). The time course of E2F induction during an
adenovirus infection is coincident with the stimulation of E2
transcription, indicating a role for E2F in the regulation
process (21). Recent experiments have now shown that the
adenovirus-mediated stimulation of E2F DNA binding activ-
ity is a multistep process. First, there is an ElA-dependent
increase in the level of DNA binding activity of the E2F
factor, not involving new synthesis of protein and possibly
as a result of an induced phosphorylation (2, 20). Second, the
interaction of E2F with the E2 promoter is further aug-
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mented by the induction of cooperative binding to the two
E2F binding sites in the E2 promoter as a result of the
interaction of a 19-kDa E4 gene product with E2F (7, 9, 16,
20). This cooperative binding, which is dependent on the
precise arrangement of E2F binding sites in the E2 promoter,
leads to the formation of a very stable DNA-protein com-
plex. Finally, recent experiments demonstrated that the E2F
factor can be found complexed to cellular proteins in many
cell types and that the E4 protein cannot interact with E2F in
such complexes. However, ElA can dissociate these com-
plexes, releasing free E2F to which the E4 protein can then
bind (1).
Our previous experiments have identified E2F binding
sites in the 5'-flanking region of a number of cellular genes
including c-myc, N-myc, and the dihydrofolate reductase
(DHFR) gene (3, 8, 15). Functional assays have demon-
strated the importance of the E2F sites in the c-myc pro-
moter for ElA-induced expression (8, 14, 25). We now show
that ElA can trans activate these other cellular genes,
dependent on the E2F sites in these promoters, indicating
that the presence of an E2F site can render a gene sensitive
to activation by ElA. Furthermore, we demonstrate a high
degree of conservation of a dyad E2F binding site within
these promoters and suggest that this site represents the
normal, cellular binding site for E2F.
MATERIALS AND METHODS
Cells and virus. Vero and LMTK- cells were obtained
from American Type Tissue Culture. Cells were grown in
Dulbecco modified Eagle medium supplemented with 10%
fetal calf serum.
Plasmids and DNA fragments. Plasmid N-myc/RlBam/
geml containing the transcriptional start site and 1,619
nucleotides of the mouse N-myc promoter was obtained
from Jeff Friedman (Rockefeller University). The chloram-
phenicol acetyltransferase (CAT) gene from plasmid
pCAT3M was cloned directly downstream of the N-myc
promoter at the Hindlll site. The full-length promoter was
deleted to position -122 by digestion with NarI, and double-
stranded oligonucleotides containing wild-type E2F binding
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sites or mutant binding sites (TTTGGATCGAAACGCTTT
GGACC) were ligated into the Narl site to reconstitute
nucleotides -123 to -142 (numbers are relative to the 5'
transcriptional start site [4]).
A XbaI-to-SmaI restriction fragment of 131 nucleotides
was isolated and end labeled with [at-32P]dATP with the
Klenow fragment of DNA polymerase for use in the gel
mobility shift analysis.
The DHFR-CAT wild-type and E2F double-mutant plas-
mids have been described previously (3). In this study,
additional site-directed mutants were constructed which
abolished either E2F site alone. The sequences of the
mutagenic oligonucleotides are shown below (with the re-
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site 1 + 2 oligonucleo- 5'-TGCAATTTCGATCCAAACTTG-3'
tide: 3'-ACGTTAAAGCTAGGTTTGAAC-5'
Probes for gel shift analysis were created by subcloning a
FokI-to-PstI fragment from plasmid pDHFR-210CAT into
BlueScript containing the CAT gene and isolating a XbaI
fragment of 142 nucleotides. This fragment was end labeled
with [oL-32P]dATP by using the Klenow fragment of DNA
polymerase.
Transfection ofDNA and CAT assays. Vero or LMTK cells
were split 1:4 in Dulbecco modified Eagle medium supple-
mented with 10% fetal calf serum 8 h prior to transfection.
Briefly, calcium phosphate precipitates (6) were formed
containing 20 jig of DNA (1 to 5 jig of target DNA and 5 to
15 ,ug of the ElA-expressing plasmid pGE1A; plasmid
pGEM2 was used as nonspecific carrier DNA). Cells were
exposed to the DNA precipitates for 12 to 16 h and then
washed with Dulbecco modified Eagle medium and placed in
Dulbecco modified Eagle medium containing 10% fetal calf
serum for 36 h before harvesting. CAT assays were per-
formed exactly as described previously (6). The plasmid
pBC12/RSV/SEAP (2 jig) was used as an internal control in
each transfection (3a).
Mobility shift assays and off-rate analysis. DNA binding
assays were performed as described by Hiebert et al. (8).
The reaction mixtures contained 1 to 4 jig of protein and 0.1
ng of a DNA fragment 32P end labeled with the Klenow
fragment of DNA polymerase. The reaction mixture was
incubated at room temperature for 30 min and analyzed on a
4% polyacrylamide gel containing 0.25 x TBE at 4°C.
Off-rate analysis was performed as described by Ray-
chaudhuri et al. (20). A standard DNA binding reaction
mixture was prepared as above, and after a 30-min incuba-
tion at room temperature, a large excess (80 ng) of specific
competitor was added, aliquots were removed at the various
time points, and the DNA-protein complexes were analyzed
immediately on a 4% polyacrylamide gel.
RESULTS
E2F binding sites in cellular promoters mediate ElA trans
activation. A computer-assisted analysis of the GenBank
data base has identified a number of cellular genes that
DHIFR [SITE 1,2 -]
FIG. 1. Schematic representation of the N-myc and DHFR wild-
type and mutant promoters. (A) Construction of the N-myc pro-
moter mutations. The full-length N-myc promoter is shown sche-
matically at the top. An N-myc promoter deleted to position -122
was constructed by isolating the small NarI-to-BamHI restriction
fragment and reintroducing this fragment back into the parent vector
after addition of a BgII linker at the Narl site. The N-myc 142 and
142 (-E2F) promoters were reconstructed from N-myc-122 by syn-
thesizing double-stranded oligonucleotides encoding nucleotides
-123 to -142 containing either wild-type or mutated E2F binding
sites. Boxes depict E2F binding sites. Arrows indicate the first
transcriptional start site. (B) The DHFR promoter (top) containing
all signals necessary for full expression (23) was used for oligonu-
cleotide-directed site-specific mutagenesis of the first (DHFR [site
1]), the second (DHFR [site 2]), or both (DHFR [site 1,2]) E2F
binding sites. WT, wild type.
contain possible binding sites for the E2F transcription
factor, and direct binding assays have confirmed that each of
these sites does indeed bind E2F (8, 15). Previous experi-
ments have demonstrated that E2F is important for basal
expression of both DHFR gene (3) and c-myc gene (19, 25)
transcription and is involved in the ElA induction of the
c-myc gene through the P2 promoter (8, 14, 25). We wished
to extend these observations to determine the functional
importance of E2F sites in other genes and thus the general
relevance of E2F to activation of cellular transcription by
EIA. Therefore, we used transient transfection assays to
compare the wild-type promoters, containing all the signals
necessary for efficient transcription, with promoters contain-
ing site-directed mutations which abolish E2F interactions.
We began our analysis by comparing an N-myc promoter
extending to -1619 relative to the cap site with promoters
deleted to -142 and containing either wild-type or mutant
E2F sites (Fig. 1). The N-myc promoter contains a single
E2F site at -120 to -127 and two overlapping E2F sites at
-142 to -131. The constructs were tested by cotransfection
with an ElA-expressing plasmid into LMTK- cells. Trans-
fection of the ElA-expressing plasmid pGElA with the
-1619 N-myc/CAT construct resulted in an approximately
fivefold stimulation of CAT activity over that seen in cells
transfected with the target plasmid alone (Fig. 2A). This
level of induction or a slightly higher level was also achieved
with the N-myc promoter deletion mutant that retained only
142 bp of upstream sequence that includes the E2F binding
sites. However, a -142 promoter containing site-directed
mutations that abolished all three possible E2F binding sites
was not responsive to ElA. These results therefore demon-
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FIG. 2. Activation of the N-myc and DHFR promoters by ElA. (A) LMTK- cells were cotransfected with 2 pLg of the N-myc-CAT
construct and 0 (-) or 10 ,ug (+) of the ElA-expressing plasmid pGE1A. The N-myc construct used is indicated below each group of lanes.
Extracts were prepared and assayed for CAT activity as described in Materials and Methods. (B) The wild-type (WT) and DHFR mutant
promoters were linked to the CAT reporter gene and cotransfected with the ElA-expressing plasmid pGE1A. Extracts were prepared 36 h
after transfection and assayed for CAT activity as described in Materials and Methods. Each transfection contained an internal control, as
described in Materials and Methods, to correct for transfection efficiencies.
and that the E2F binding sites are required for this activa-
tion.
The DHFR promoter is also efficiently trans activated by
adenovirus ElA as shown in Fig. 2B. Recent experiments
have indicated that sequences within 147 bp of the DHFR
major transcription start site contain all the signals necessary
for efficient transcription (23). This minimal promoter has
been demonstrated to contain two overlapping E2F binding
sites, similar to those found at -142 to -131 in the N-myc
promoter (Fig. 1), located at positions +3 to +13 relative to
the major transcription start site (Fig. 2A). To determine the
importance of these sites for ElA trans activation, we used
cotransfection assays to test DHFR promoters that were
truncated to position -147 and which contained either
wild-type or mutant E2F binding sites (Fig. 2B). Cotransfec-
tion of the -147 DHFR promoter with the ElA-expressing
plasmid resulted in a 5- to 10-fold stimulation of transcription
from the DHFR promoter. Mutation of both of the E2F
binding sites virtually abolished trans activation by ElA.
Thus, as was the case for the N-myc promoter, the E2F
binding sites are critical for trans activation of the DHFR
promoter by ElA. From these results, as well as previous
experiments (8, 25), we conclude that the c-myc, N-myc, and
DHFR promoters are all responsive to ElA trans activation
and that this response is dependent on E2F binding.
A single E2F recognition site is sufficient for ElA trans
activation. An inspection of the E2F binding sites within the
ElA-regulated genes revealed a common motif differing
from that found in the adenovirus type 5 E2 promoter. The
DHFR, N-myc, and c-myc promoters each contain a motif
consisting of two E2F binding sites which, while oriented in
the same manner as in the E2 promoter, overlap by 4 bp,
forming a near-perfect dyad repeat (Fig. 3). In contrast,
although the E2F sites in the E2 promoter also are a dyad
repeat, the centers of the elements in the E2 promoter are
separated by 25 bp or slightly more than two helical turns.
The functional significance of a nucleotide sequence is often
suggested by evolutionary conservation, and such an analy-
sis of these E2F recognition sites is summarized in Fig. 3.
Clearly, the dyad symmetry of the overlapping E2F recog-
nition site motif is highly conserved through evolution. This
is particularly striking in the DHFR locus, where this se-
quence is absolutely conserved among human, hamster, and
mouse genes. In fact, this element shows greater conserva-
tion than the DHFR coding sequence. Interestingly, this
motif is also present in the adenovirus type 5 ElA enhancer,
and a comparison of the adenovirus ElA enhancer sequence
in a variety of viral serotypes reveals strong conservation.
As the ElA gene must be expressed immediately upon
infection, it is perhaps not surprising that it contains tran-
scription factor binding motifs similar to that found in
cellular promoters. One might presume that the ElA gene
must function as a cellular promoter without the benefit of
alterations induced by the ElA gene products or other early
viral genes such as E4.
Although the E2F binding sites in four independent pro-
moters conserve this motif, this arrangement is not critical
for the ElA trans activation event. We mutated either half of
the element or the entire element in the context of the DHFR
promoter (Fig. 1). The constructs were transfected into
LMTK- cells with or without pElA. As shown in Fig. 2B,
mutation of one-half of the element, regardless of which half
was mutated, did not eliminate ElA trans activation. Muta-
tion of the entire element, however, abolished the response
to ElA. The data shown in Fig. 2B are representative of
multiple experiments performed in both LMTK- and Vero
cell types and have been corrected for minor fluctuations in
transfection efficiency. We therefore conclude that although
the overlapping sites are highly conserved, only one-half of
this motif, representing a single E2F recognition site, is
required for a response to ElA, consistent with previous
results (13). It does appear, however, that optimal activity
requires the full site, since the extent of trans activation was
reduced with each of the half-site mutants, particularly the
site 2 mutant. This is also consistent with other experiments
in which the constitutive basal activity of the single-site
mutants has been lower than that of the wild-type DHFR
promoter, depending on the growth state of the cells at the
time of transfection (26).













































FIG. 3. Conserved E2F binding site motif. (A) E2F binding sites
in the adenovirus type 5 E2 promoter and DHFR promoter. Arrows
indicate the relative 5'-to-3' orientation of the binding site. (B)
Conservation of the dyad E2F binding site present in cellular genes
and the viral ElA gene. Hu, human; Si, simian; Ad2, adenovirus
type 2; SA7P, simian adenovirus type 7P.
tive E2F binding. The results presented in Fig. 2 demonstrate
that an E2F site in the DHFR promoter is required for
ElA-mediated trans activation. Previous studies with the
adenovirus E2 promoter have shown that the normal activa-
tion involves an ElA-dependent stimulation of E2F binding
activity as well as an induced cooperativity of E2F binding
dependent on the product of the early E4 gene (7, 20). Since
this is dependent on E4, as well as the precise arrangement
of sites in the E2 promoter, it would seem unlikely that
cooperative binding of E2F contributes to activation of the
DHFR gene by ElA. Indeed, comparison of E2F binding to
a DHFR promoter containing both sites in the dyad motif
versus a promoter containing mutations in the first site, the
second site, or both E2F sites indicated that only a single
complex could form on the promoter, at least in vitro, and
that there was no indication of cooperativity (Fig. 4A).
Furthermore, using extracts containing the E4 protein also
caused no alteration in the pattern of DNA-protein com-
plexes, suggesting that the E4 protein also could not induce
a cooperative interaction.
The lack of a cooperative interaction between two factors
is also shown by a dissociation rate analysis depicted in Fig.
4C. The E2F DNA complex was formed with the promoters
containing the dyad E2F site, and after equilibrium was
reached, an excess of cold DNA was added and the stability
of the complex was measured. In contrast to the cooperative
binding of the E2F-E4 complex on the E2 promoter that
results in the formation of a very stable DNA-protein com-
plex (7, 20), the interaction of E2F with the DHFR promoter,
the N-myc promoter, or the c-myc promoter was unstable as
indicated by the rapid dissociation rate. The half-life of the
complex was less than 5 min, independent of the source of
E2F. We therefore conclude that although there are two
potential E2F sites in the DHFR promoter, only a single E2F
complex is formed, at least as measured in in vitro binding
assays.
DISCUSSION
These experiments illustrate several important points.
First, transcription from the N-myc and DHFR promoters
can be stimulated by the adenovirus ElA gene product.
Second, these promoters contain sequences that interact
with the E2F transcription factor, and these sequences are
required for the ElA-mediated trans activation of these
promoters. Finally, the identification of E2F binding sites in
multiple cellular promoters has led to the recognition of a
cellular E2F binding site which is composed of two overlap-
ping half-sites. Although the conservation suggests a func-
tional importance, only a single E2F site (a half-site) is
required for ElA trans activation. We suspect that the
majority of the ElA effect through E2F is the result of a
stimulation of E2F DNA binding activity, dependent on
ElA, that may involve phosphorylation of the factor (2, 20).
This results in an increased concentration of active factor
that can bind to DNA. Recent experiments also demonstrate
that E2F can be found in complexes with cellular proteins
and that ElA can dissociate E2F from these complexes (1).
If these complexes are inhibitory for transcription, then this
action of ElA may also contribute to the trans activation of
an E2F-dependent promoter.
Whether ElA can trans activate every gene that may
possess an E2F binding site is not clear, but the fact that
each gene thus far assayed does respond in this way indi-
cates that this may be a general phenomenon. Although our
assays have utilized transient transfections to measure the
effects of ElA and the role of the E2F elements in this
control, our previous experiments have shown that the
endogenous c-myc gene is stimulated by adenovirus infec-
tion (8). Moreover, other experiments have shown that
amplified, endogenous DHFR genes were stimulated by
adenovirus infection (30). Subsequent experiments by these
investigators suggested that the activation was posttran-
scriptional since transcription rates appeared to be un-
changed (29). However, since the transcription rates mea-
sured in these experiments were quite low, such a
conclusion must be considered tenuous. Our findings con-
cerning the role of the E2F transcription factor in the
ElA-mediated activation of the DHFR gene would suggest
that at least one component of this activation involves
control of transcription initiation.
These results also underscore the fact that ElA-mediated
activation of transcription can be specific and can require a
distinct promoter element, in this case an E2F binding site.
Other reports have suggested that ElA trans activation was
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specific promoter element, leading to the interpretation that
general transcription factors may be targeted (11, 24, 27). A
more likely explanation is that some promoters may contain
multiple ElA-responsive elements such that the elimination
of any one is not sufficient to prevent trans activation.
Furthermore, it is also clear that a TATA factor can be
targeted by ElA (22, 28), and in many cases, this is likely
responsible for the general activation that is observed. The
results we present here clearly show that a unique site can be
critical for ElA trans activation.
Our analyses also suggest that the E2F binding sites in
these celular promoters are intrinsically different from those
present in the adenovirus E2 promoter. The E2 promoter
contains two EZF sites that together form a dyad repeat
separated by 25 bp. This arrangement is critical for the
cooperative binding of the E2F-E4 protein complex since
any alteration in the spacing or orientation of the recognition
sites prevents stable complex formation (7, 20). As far as we
are aware, this precise arrangement is found only in the E2
promoter. This unique arrangement of the E2F sites in the
E2 promoter is critical for the stable binding of the E2F-E4
complex (7, 20). In contrast, the E2F recognition element
found in the DHFR promoter consists of an overlapping
motif that places the two E2F binding sites on opposite sides
of the DNA helix. Interestingly, this motif is also conserved
E2 DHFR DHFR1 DHFR2 DHFR,12
B IIr-
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FIG. 4. Interaction of E2F with the DHFR promoter. (A) Re-
striction fragments of the DHFR promoter containing the dyad E2F
binding sites or mutations in the first site (DHFR,), the second site
(DHFR2), or both sites (DHFR1+2) were 3' end labeled and used to
measure E2F DNA binding in DNA mobility shift assays with HeLa
cell nuclear extract as the source of E2F. -, assay with no
competitor added; +, assay containing 10 ng of an E2 promoter
fragment containing E2F binding sites. (B) Mobility shift analysis
with partially purified E2F from adenovirus type 5-infected HeLa
cells. DHFR probes are the same as in panel A. E2, E2 promoter
fragment containing both E2F binding sites. Lanes a, shift assay
with no competitor; lanes b, shift assay containing E2 promoter
fragments as a competitor; lanes c, shift assay containing no E2F.
(C) Off-rate analysis of E2F binding to the DHFR promoter. The
E2F-DNA complex was allowed to form for 30 min on 32P-end-
labeled DNA fragments from the E2 promoter or the DHFR
promoter before a large excess of cold competitor DNA was added.
Samples were removed at the times indicated and immediately
loaded onto a native 4% polyacrylamide gel.
in the ElA enhancer of various serotypes of adenovirus. Of
the six serotypes available in the DNA sequence library
(GenBank), five contain a perfect match of the dyad binding
site (adenovirus types 2, 3, 4, 5, and 7), while adenovirus
type 12 contains a 10 of 12 bp match. The high degree of
conservation of this overlapping motif in both cellular and
viral regulatory elements strongly suggests that it is of
functional significance.
Although it is possible that the arrangement of E2F sites in
the DHFR promoter is for the same purpose as the arrange-
ment of sites in the E2 promoter, to allow cooperative
binding of a yet-to-be-identified E2F protein complex, we
found no evidence for such specificity. We believe that there
is likely another explanation for the conservation of this
element. A common theme of DNA recognition is the
binding of protein dimers to a recognition site with dyad
symmetry, each subunit of the dimer making contact with
one half-site of the recognition sequence. Although there is
no evidence to support the notion that E2F binds as a dimer,
there is also no evidence against it. We suggest that this is
the normal mode of E2F binding and that the motif found in
the DHFR promoter is the full site optimal for binding. In
this context, the full site is likely not found in the E2
promoter because of the altered binding properties induced
by the E4 protein. The E2F protein can bind a half-site, as
present in the E2 promoter or in the DHFR mutants, but
presumably with somewhat reduced affinity. Indeed, recent
assays suggest a slightly increased half-life on the full site
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increase in the level of E2F active in DNA binding brought
about by ElA (20) would then obscure any such difference in
binding affinity.
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